Biotech

All Articles

Lykos are going to ask FDA to rethink its own selection observing rejection of MDMA therapy for trauma

.Following a bad showing for Lykos Therapies' MDMA prospect for post-traumatic stress disorder at a ...

AN 2 fifty percents census, quits period 3 test after information dissatisfy

.AN2 Therapies is actually rethinking its own business in feedback to uninspired midphase informatio...

Merck spends $700M for bispecific, spying autoimmune opening and also possibility to challenge Amgen in cancer cells

.Merck &amp Co. is paying $700 thousand in advance to test Amgen in a blood cancer cells market. The...

Gilead pays out J&ampJ $320M to go out licensing package for seladelpar

.With Gilead Sciences on the verge of an FDA choice for its own liver disease medication seladelpar,...

' All palms on deck' at Lilly as peers target weight problems market

.CEO David Ricks may find the firms setting up tents at basecamp responsible for Eli Lilly in an att...

Entero giving up team, vacating office and stopping R&ampD

.Bed Liquidators has switched Entero Rehabs white colored as a piece. The lender got Entero to repay...

Exelixis loses ADC after deciding it's no suit for Tivdak

.Exelixis is surrendering on its cells element (TF)- targeting antibody-drug conjugate after ending ...

Relay dislikes SHP2 inhibitor after Genentech leaves behind

.3 full weeks after Roche's Genentech unit walked away from an SHP2 inhibitor pact, Relay Therapeuti...

Stoke's Dravet syndrome med launched of predisposed clinical hold

.Stoke Rehabs' Dravet syndrome medication has actually been actually freed from a partial hold, gett...

Fierce Biotech's Gabrielle Masson presents Intense 15 at NYSE

.Ferocious Biotech Affiliate Editor Gabrielle Masson showed the 2024 training class of Strong 15 win...